Clinical Trial Update: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of volanesorsen in familial chylomicronemia syndrome completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Chylomicronemia Syndrome

Drugs mentioned

• Volanesorsen (volanesorsen)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Familial Chylomicronemia Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-04-13